3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
7
NET
1
Gastrointestinal
1
Conditions
Neuroendocrine Tumors
143
Gastro-enteropancreatic neuroendocrine tumor
29
Carcinoma, Neuroendocrine
18
Neoplasms
15
Breast Neoplasms
13
Adenoma, Islet Cell
13
Prostatic Neoplasms
11
Carcinoma, Hepatocellular
11
Carcinoid Tumor
11
Stomach Neoplasms
10
Pheochromocytoma
10
Pancreatic Neoplasms
10
Colorectal Neoplasms
10
Sarcoma
9
Paraganglioma
9
Thyroid Neoplasms
8
Neoplasm Metastasis
8
Lung Neoplasms
8
Cholangiocarcinoma
8
Small Cell Lung Carcinoma
7
Ovarian Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Anus Neoplasms
7
Rectal Neoplasms
6
Mesothelioma
6
Colonic Neoplasms
6
Carcinoma
6
Brain Neoplasms
6
Uterine Cervical Neoplasms
5
Interventions
lanreotide
1
Octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acromegaly
×
NET
×
1 year
×
Clear all
NCT05364944
2025-11-17
OXTEND-01
Debiopharm International SA
Phase 1
Terminated
19 enrolled